Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3577325

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C[C@H](NC(=O)[C@@H](CC1CCCCC1)NC(=O)N[C@@H](CCCCN)C(=O)O)C1CCCCC1

Basic Information

ChEMBL ID CHEMBL3577325
Phase Preclinical
Structure Type MOL
InChI Key AFPITHMSIWIQKS-DZFGPLHGSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

452.6
MW (Da)
3.29
ALogP
4
HBA
5
HBD
133.6
PSA (Ų)
0.29
QED
0
Ro5 Violations
12
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C24H44N4O4
MW 452.64
Aromatic Rings 0
Heavy Atoms 32
NP-Likeness 0.09

Activity Summary

IC50 1 meas. best 6.89

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Carboxypeptidase B2
CHEMBL3419
IC50 6.89 6.89 130.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Carboxypeptidase B2 IC50 = 130.0 nM 6.89 Inhibition of human activated TAFI incubated for 15 mins by microtiter plate rea... 25990761

Literature References

PubMed DOI Target Context # Activities
25990761 10.1021/jm501840b Carboxypeptidase B2 1

Data from ChEMBL 36 via Core Engine